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Abstract
Anomalies associated with breast development are common, presenting as supernumerary nipples (polythelia) and less
often as supernumerary breast (polymastia) in 1–5% of population. These anomalies are more common in women and also
most frequently located along the mammary line, extending from the axilla to pubic region. The axillary polymastia is the
most common variant of ectopic breast tissue (EBT). EBTcan undergo the same physiological and pathological processes
as the normal breast. The incidence of ﬁbroadenoma developing in ectopic breast is a rare entity, most common being the
carcinoma. We report here a case of ﬁbroadenoma of EBT in both axillae of a 33-year-old Asian woman. This case has
been reported for its rarity and to reemphasize the importance of screening of EBT for any pathology during routine
screening of breast.
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Introduction
Polymastia is a term used to describe the presence of
more than two breasts with or without nipple–areola complex
in human beings. It is synonymous with supernumerary or
ectopic breast tissue (EBT). Axillary breast tissue is a common
variant of EBT. Diagnosis of EBT is important because it
shows similar pathological changes that occur in normally
positioned breast and can be a marker for urogenital and
cardiovascular malformation or urogenital malignancies.[1,2]
Case Report
A 33-year-old woman was admitted in our hospital with
complaints of bilateral lumps in preexisting axillary swellings
(20 years) for the past 3 months. The painless lumps were
insidious in onset and slow in progression. The bilateral
preexisting axillary swellings were present since the adoles-
cent age. On local examination, both axillary tails of the breast
were enlarged and palpable lumps measuring about 3  2 cm,
which were freely mobile within the enlarged axillary tails, were
found [Figure 1]. Also, the patient was not associated with
other congenital anomalies.
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Figure 1: Patient with bilateral axillary tail
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Ultrasonogram of the breasts and axillae was conducted,
which showed a single discrete lump in both enlarged axillary
tails and normal breasts. Fine-needle aspiration cytology
(FNAC) of both lumps was conducted and ﬁbroadenoma of
axillary tails was diagnosed [Figure 2]. En masse excision of
both axillary tails was done [Figure 3] and the specimens
[Figure 4] were sent for histopathological study. Both mass
lesions in the axillary tail were conﬁrmed as ﬁbroadenoma by
the histopathology results [Figure 5].
Discussion
During the sixth week of embryonic life, the mammary milk
lines, which represent two ectodermal thickenings, develop
along the side of the embryo, extending from the axillary
region to the groin. In normal development, most of the
embryological mammary ridges resolve, except for two
segments in pectoral region, which later become breast.
Failure of any portion of the mammary ridge to involute may
lead to ectopic breast with (polythelia) or without (polymastia)
a nipple–areola complex.[1–3] Polythelia may associate with
urinary anomalies such as supernumerary kidneys, failure of
renal formation, and renal carcinoma. Usually, ECT occurs
sporadically, but a hereditary predisposition has also been
reported.[2,4]
Most of EBToccur along the milk line in the axilla, but other
than the milk line region its occurrence in areas such as the
perineum, face, lumbar region, and vulva has been reported in
literature.[1–3] Supernumerary tissues present in any location
other than along the milk line are supported by two beliefs:
1. A migratory arrest of breast primordium during chest wall
development
2. Development from the modiﬁed apocrine sweat gland[2,4]
In 1915, Kajava described a classiﬁcation system for
supernumerary breast tissue, which is commonly used
Figure 2: FNAC of mass in the axillary tail shows features suggestive
of ﬁbroadenoma
Figure 3: En masse excision of both axillary tails
Figure 4: Gross specimens of both side ﬁbroadenoma
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today[2,4]: Class I—complete breast with nipple, areola, and
glandular tissue; Class II—nipple and glandular tissue but no
areola; Class III—areola and glandular tissue but no nipple;
Class IV—glandular tissue only; Class V—nipple and areola
but no glandular tissue; Class VI—nipple only; Class VII—areola
only; Class VIII—patch of hair only (polythelia pilosa).
According to the literature, the incidence of these anoma-
lies ranges between 1% and 6%, being more common among
blacks, Jews, and Japanese. Gilmore et al. from their study on
a population of American women found that supernumerary
nipple and accessory breast tissue were more common in the
Native American women than in the non-native women. Their
study indicates the role of genetic basis in the development of
these breast anomalies, and similar observations have been
published by Klinkerfuss and Hersh et al. [4]
The clinical signiﬁcance of supernumerary breast, apart
from cosmetic and psychological impacts, falls into the
susceptibility to same physiological and pathological changes
affecting normal breast. As compared to normally positioned
breast tissue, EBT shows the same hormonal effects. During
menses or pregnancy, hormonal stimulation may cause enlarge-
ment and discomfort. EBT can undergo lactational changes
during pregnancy, and in the presence of a nipple–areola
complex, it can give rise to lactational secretion.[1,4]
EBT is subject to hormonal response and may develop
benign and malignant pathologic processes similar to those
seen in normally located breast tissues, including ﬁbrocystic
disease, ﬁbroadenoma, inﬂammatory disease, intraductal
papilloma, lactating adenoma, and carcinoma.[1,4] Although
carcinoma of the axillary accessory breast is rare, accounting
for 0.3% of all breast cancers, the most frequent condition
in the accessory breast cancer followed by mastopathy/
inﬂammatory condition and ﬁbroadenoma.
Tumors in supernumerary breast tissue should be diag-
nosed using the same methods applied to normal breast
tissue (mammography, ultrasonography, cytology, and exci-
sion biopsy of the nodule in axilla), with observation of speciﬁc
indications. However, due to the low incidence of such tumors,
diagnosis may be delayed or even ignored, thus making
treatment more difﬁcult. When tumors or nodules are found
along the mammary line, the presence of breast tissue should
be considered during investigation.[5,6]
Few cases of ﬁbroadenoma in the axilla have been
reported in literature. To the best of our knowledge, only one
case of ﬁbroadenoma in bilateral EBT in axilla has been
reported.[7]
Axillary breast tissue can be represented by ectopic tissue
not connected to the breast. It may also be connected to
the external part of thoracic breast; in this case, it is called the
axillary tail of Spence. EBT, especially when found in the axilla,
is located in the subcutaneous tissue and deep dermis of the
skin, where it often mingles with normal skin appendage
glands. For the pathologist, it may be difﬁcult to distinguish
between tumors of skin appendage gland origin and mammary
origin. This may explain the cytological report in our case that
suggested an adnexal tumor.[8]
The diagnosis of EBT is strongly suggested by the history
of cyclic changes during the menstrual period or by the initial
appearance during pregnancy. Evidence from the natural
history of ﬁbroadenoma of breast suggests that less than 5%
of these tumors increase whereas approximately one-fourth
decrease in size. This case shows a rare occurrence of
ﬁbroadenoma in an axillary supernumerary breast. Although
the benign nature and natural history of ﬁbroadenoma are well
known, biopsy should be considered for women aged 40 years
or older due to the increased rate of cancer in this age range.[9]
Among women of this age, if conservative management is
chosen, periodic clinical and mammographic control is
required, following negative results of cytological tests. The
need for careful investigation of supernumerary breast tissue
should be emphasized, because it may be affected by benign
and malignant diseases.[5]
If EBT is associated with any suspicion of pathology, then
further investigation using methods such as FNAC, ultrasono-
gram, mammography, and biopsy should be conducted as for
any other breast lesion.[10] In routine screening programs for
breast cancer, a clinical examination should be made for the
presence of EBT, and, if present, that should be subjected to
routine screening as well, along with the normally positioned
breast.
Conclusion
To conclude, ﬁbroadenoma should be kept in mind in the
differential diagnosis of axillary swellings. Fibroadenoma in
EBT should be diagnosed with the same methods applied
to normal breast tissue (mammography, ultrasonography,
cytology, and biopsy). When tumors or nodules are found
Figure 5: Microscopic picture of ﬁbroadenoma
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along the mammary line, the presence of breast tissue should
be considered during the investigation. The patients should be
evaluated for any associated urogenital and cardiac anomaly.
References
1. Ciralik H, Bulbuloglu E, Arican O, Citil R. Fibroadenoma of the
ectopic breast of the axilla: a case report. Pol J Pathol 2006;57
(4):209–11.
2. Amaranathan A, Balaguruswamy K, Bhat RV, Bora MK. An
ectopic breast tissue presenting with ﬁbroadenoma in axilla. Case
Rep Surg 2013;2013:3 pages.
3. Rizvi G, Pandey H, Gupta MK. Fibroadenoma of the ectopic
breast in axilla. J Case Rep 2012;2(2):36–8.
4. Aughsteen AA, Almasad JK, Al-Muhtaseb MH. Fibroadenoma
of the supernumerary breast of the axilla. Saudi Med J 2000;21
(6):587–9.
5. Conde DM, Torresan RZ, Kashimoto E, Carvalho LE, Cardoso
Filho C. Fibroadenoma in axillary supernumerary breast: case
report. Sao Paulo Med J 2005;123(5):253–5.
6. Lages RB, T Goncalves Neto TR, Belchior Cabral RF, Araujoa
RC, Vieiraa SC. Fibroadenoma of the axilla in a patient with
macroprolactinoma. J Med Cases 2011;2(6):279–83.
7. Gentile P, Izzo V, Cervelli V. Fibroadenoma in the bilateral
accessory axillary breast. Aesthetic Plast Surg 2010;34:657–9.
8. Mukhopadhyay M, Saha AK, Sarkar A. Fibroadenoma of the
ectopic breast of the axilla. Indian J Surg 2010;72(2):143–5.
9. Shindholimath VV, Ghongdemath JS, Lingegowda K, Ammanagi
AS. Fibroadenoma of the axillary breast. Indian J Med Special
2012;3(2):220–1.
10. Chung-Park M, Liu CZ, Giampoli EJ, Emery JD, Shalodi A.
Mucinous adenocarcinoma of ectopic breast tissue of the vulva.
Arch Pathol Lab Med 2002;126(10):1216–8.
How to cite this article: Rajkumar B, Anbarasu S, Rajagopal L.
Bilateral ﬁbroadenoma of the ectopic breast tissue in axilla:
Int J Med Sci Public Health 2015;4:138-141
Source of Support: Nil, Conﬂict of Interest: None declared.
International Journal of Medical Science and Public Health | 2015 | Vol 4 | Issue 1 141
Rajkumar et al.: Bilateral Fibroadenoma of the ectopic breast tissue in axilla
